48,448
edits
Difference between revisions of "Neuroendocrine tumour of the pancreas"
Jump to navigation
Jump to search
Neuroendocrine tumour of the pancreas (view source)
Revision as of 14:50, 4 March 2014
, 14:50, 4 March 2014→IHC
(→IHC) |
|||
| Line 50: | Line 50: | ||
Note: | Note: | ||
*''CK19'' should '''not''' be confused with ''CA19-9''. | *''CK19'' should '''not''' be confused with ''CA19-9''. | ||
==Sign out== | |||
<pre> | |||
TAIL OF PANCREAS AND SPLEEN, DISTAL PANCREATECTOMY AND SPLENECTOMY: | |||
- CYSTIC PANCREATIC NEUROENDOCRINE TUMOUR. | |||
- UNREMARKABLE SURROUNDING PANCREAS WITH FAT. | |||
- SPLEEN WITHIN NORMAL LIMITS. | |||
- FOUR BENIGN LYMPH NODES. | |||
- NEGATIVE FOR MALIGNANCY. | |||
</pre> | |||
===Micro=== | |||
The sections show pancreas with a large well-circumscribed tumour that centrally has a large cyst-like cavity. The tumour cells have moderate pale grey cytoplasm and round nuclei with salt and pepper chromatin. The tumour cells are arranged in cords and nests. No cholesterol clefts are readily apparent. No hyaline globules are identified. No papillary structures are apparent. | |||
No necrosis is identified. No degenerative changes are apparent. Mitotic activity is seen focally. There are 2 mitoses per 10 high power fields, were one high power field has an area of 0.2376 mm*mm. | |||
==See also== | ==See also== | ||